Building human artery and vein endothelial cells from pluripotent stem cells, and enduring mysteries surrounding arteriovenous development
Seminars in Cell & Developmental Biology · 2024-03 · 155 · 62-75
DOI: 10.1016/j.semcdb.2023.06.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cell & Developmental Biology, 2024-03. Verfasst von Kyle M Loh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford …. Hauptthemen laut MEDLINE: Endothelial Cells, Pluripotent Stem Cells. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: NIH HHS, U.S. National Institutes of Health (NIH Director’s Early Independence Award, California Institute for Regenerative Medicin.
Abstract (Originalsprache)
Owing to their manifold roles in health and disease, there have been intense efforts to synthetically generate blood vessels in vitro from human pluripotent stem cells (hPSCs). However, there are multiple types of blood vessel, including arteries and veins, which are molecularly and functionally different. How can we specifically generate either arterial or venous endothelial cells (ECs) from hPSCs in vitro? Here, we summarize how arterial or venous ECs arise during embryonic development. VEGF and NOTCH arbitrate the bifurcation of arterial vs. venous ECs in vivo. While manipulating these two signaling pathways biases hPSC differentiation towards arterial and venous identities, efficiently generating these two subtypes of ECs has remained challenging until recently. Numerous questions remain to be fully addressed. What is the complete identity, timing and combination of extracellular signals that specify arterial vs. venous identities? How do these extracellular signals intersect with fluid flow to modulate arteriovenous fate? What is a unified definition for endothelial progenitors or angioblasts, and when do arterial vs. venous potentials segregate? How can we regulate hPSC-derived arterial and venous ECs in vitro, and generate organ-specific ECs? In turn, answers to these questions could avail the production of arterial and venous ECs from hPSCs, accelerating vascular research, tissue engineering, and regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA. Electronic address: kyleloh@stanf…
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: layteng@stanford.edu.
Förderung
- NIH HHS
- U.S. National Institutes of Health (NIH Director’s Early Independence Award
- California Institute for Regenerative Medicin
Zitieren
APA
Loh, K. M., & Ang, L. T. (2024). Building human artery and vein endothelial cells from pluripotent stem cells, and enduring mysteries surrounding arteriovenous development. Seminars in Cell & Developmental Biology, 155, 62-75. https://doi.org/10.1016/j.semcdb.2023.06.004
Vancouver
Loh KM, Ang LT. Building human artery and vein endothelial cells from pluripotent stem cells, and enduring mysteries surrounding arteriovenous development. Seminars in Cell & Developmental Biology. 2024;155:62-75. doi:10.1016/j.semcdb.2023.06.004
BibTeX
@article{Loh2024,
author = {Loh, Kyle M and Ang, Lay Teng},
title = {Building human artery and vein endothelial cells from pluripotent stem cells, and enduring mysteries surrounding arteriovenous development},
journal = {Seminars in Cell & Developmental Biology},
year = {2024},
volume = {155},
pages = {62--75},
doi = {10.1016/j.semcdb.2023.06.004}
}
EUVIMED